Variant report

Variant	nsv825950
Chromosome Location	chr11:65103396-65105970
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1)
CpG islands
(count:61)
Chromatin interactive
region (count:19)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	POLR2A	chr11:65104656-65104879	HepG2	liver:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:65104563-65104613	AG10803	skin:	n/a
2	chr11:65104563-65104613	PFSK-1	brain:	n/a
3	chr11:65104563-65104613	NB4	blood:	n/a
4	chr11:65104563-65104613	IMR90	lung:	fetal
5	chr11:65104563-65104613	K562	blood:	n/a
6	chr11:65104563-65104613	HEK293	kidney:	embryo
7	chr11:65104563-65104613	H1-hESC	embryonic stem cell:	embryo
8	chr11:65104563-65104613	HRCEpiC	kidney:	n/a
9	chr11:65104563-65104613	ovcar-3	ovarian:	n/a
10	chr11:65104563-65104613	SK-N-SH	brain:	n/a
11	chr11:65104563-65104613	U87	brain:	n/a
12	chr11:65104563-65104613	HRE	kidney:	n/a
13	chr11:65104563-65104613	HIPEpiC	eye:	n/a
14	chr11:65104563-65104613	BE2_C	brain:	n/a
15	chr11:65104563-65104613	MCF-7	breast:	n/a
16	chr11:65104563-65104613	HNPCEpiC	eye:	n/a
17	chr11:65104563-65104613	SAEC	small airway:	n/a
18	chr11:65104563-65104613	PrEC	prostate:	n/a
19	chr11:65104563-65104613	HL-60	blood:	n/a
20	chr11:65104563-65104613	ProgFib	skin:	n/a
21	chr11:65104563-65104613	HCF	heart:	n/a
22	chr11:65104563-65104613	HRPEpiC	eye:	n/a
23	chr11:65104563-65104613	AoSMC	blood vessel:	n/a
24	chr11:65104563-65104613	Caco-2	colon:	n/a
25	chr11:65104563-65104613	Hepatocyte	liver:	n/a
26	chr11:65104563-65104613	SK-N-SH_RA	brain:	n/a
27	chr11:65104563-65104613	GM12892	blood:	n/a
28	chr11:65104563-65104613	AG09309	skin:	n/a
29	chr11:65104563-65104613	AG04449	skin:	fetal
30	chr11:65104563-65104613	NH-A	brain:	n/a
31	chr11:65104563-65104613	BJ	skin:	n/a
32	chr11:65104563-65104613	RPTEC	kidney:	n/a
33	chr11:65104563-65104613	Hela-S3	cervix:	n/a
34	chr11:65104563-65104613	HEEpiC	esophagus:	n/a
35	chr11:65104563-65104613	HMEC	breast:	n/a
36	chr11:65104563-65104613	MCF10A-Er-Src	breast:	n/a
37	chr11:65104563-65104613	SK-N-MC	brain:	n/a
38	chr11:65104563-65104613	HPAEpiC	pulmonary alveolar:	n/a
39	chr11:65104563-65104613	GM06990	blood:	n/a
40	chr11:65104563-65104613	NT2-D1	testis:	n/a
41	chr11:65104563-65104613	Jurkat	blood:	n/a
42	chr11:65104563-65104613	HepG2	liver:	n/a
43	chr11:65104563-65104613	LNCaP	prostate:	n/a
44	chr11:65104563-65104613	GM12891	blood:	n/a
45	chr11:65104563-65104613	HCT-116	colon:	n/a
46	chr11:65104563-65104613	CMK	blood:	n/a
47	chr11:65104563-65104613	SKMC	muscle:	n/a
48	chr11:65104563-65104613	GM19239	blood:	n/a
49	chr11:65104563-65104613	GM12878	blood:	n/a
50	chr11:65104563-65104613	ECC-1	luminal epithelium:	n/a

(count:19 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:65101528..65104353-chr11:65197990..65200376,2	K562	blood:
2	chr11:65104850..65107379-chr11:65266146..65268534,3	K562	blood:
3	chr11:65081631..65084592-chr11:65099872..65104597,5	K562	blood:
4	chr11:65099880..65103900-chr11:65265146..65267934,3	MCF-7	breast:
5	chr11:65102149..65103973-chr11:65118677..65120435,2	MCF-7	breast:
6	chr11:65103664..65107529-chr11:65109355..65112247,3	MCF-7	breast:
7	chr11:65099781..65103974-chr11:65120675..65126515,7	MCF-7	breast:
8	chr11:65027562..65030484-chr11:65105645..65108132,2	MCF-7	breast:
9	chr11:65105171..65109589-chr11:65119360..65123181,4	K562	blood:
10	chr11:65105589..65107850-chr11:65341352..65343496,2	K562	blood:
11	chr11:65101646..65104320-chr11:65195923..65197643,2	K562	blood:
12	chr11:65100322..65103953-chr11:65104304..65109119,7	MCF-7	breast:
13	chr11:65100243..65104610-chr11:65105410..65109851,8	K562	blood:
14	chr11:65105160..65107912-chr11:65564139..65566619,2	MCF-7	breast:
15	chr11:65104784..65106691-chr11:65276749..65278262,2	K562	blood:
16	chr11:65077010..65079617-chr11:65101633..65103467,2	K562	blood:
17	chr11:65100243..65104610-chr11:65105410..65109851,8	K562	blood:
18	chr11:65100322..65103953-chr11:65104304..65109119,7	MCF-7	breast:
19	chr11:65100635..65103447-chr11:65112370..65113916,2	K562	blood:

No data

Variant related genes	Relation type
DPF2	TF binding region
DPF2	CpG island
ENSG00000133884	chromatin interactions
ENSG00000014138	chromatin interactions
ENSG00000270117	chromatin interactions
ENSG00000251562	chromatin interactions
ENSG00000255404	chromatin interactions
ENSG00000149798	chromatin interactions
ENSG00000173825	chromatin interactions

Extended variants
information (count: 120 )
Associated
traits (count: 99 )

Variant overlapped rSNPs/rCNVs (count:120 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs530106314	chr11:65103412-65103413	Weak transcription Strong transcription Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
2	rs375718927	chr11:65103530-65103531	Weak transcription Strong transcription Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs543883928	chr11:65103555-65103556	Weak transcription Strong transcription Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs563749978	chr11:65103577-65103578	Weak transcription Strong transcription Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs555569295	chr11:65103584-65103585	Weak transcription Strong transcription Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs532684891	chr11:65103609-65103610	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
7	rs552311717	chr11:65103701-65103702	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs142361667	chr11:65103705-65103706	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
9	rs528339251	chr11:65103713-65103714	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs548180789	chr11:65103727-65103728	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
11	rs657005	chr11:65103742-65103743	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
12	rs540341	chr11:65103743-65103744	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
13	rs642848	chr11:65103751-65103752	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
14	rs642860	chr11:65103760-65103761	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
15	rs656964	chr11:65103761-65103762	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs188235212	chr11:65103821-65103822	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
17	rs192776998	chr11:65103836-65103837	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
18	rs572194462	chr11:65103841-65103842	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
19	rs376305567	chr11:65103861-65103862	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs556576844	chr11:65103885-65103886	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs184393950	chr11:65103887-65103888	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs541157498	chr11:65103891-65103892	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
23	rs189071111	chr11:65103907-65103908	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs150974833	chr11:65103922-65103923	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs367837666	chr11:65103923-65103924	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs559063343	chr11:65103990-65103991	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs113775426	chr11:65103998-65103999	Weak transcription Strong transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs577754714	chr11:65104033-65104034	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs543047516	chr11:65104157-65104158	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs541650096	chr11:65104185-65104186	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs554959817	chr11:65104199-65104200	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs180958832	chr11:65104228-65104229	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs373816969	chr11:65104241-65104242	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs543823429	chr11:65104250-65104251	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs59621783	chr11:65104254-65104255	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs369445020	chr11:65104257-65104258	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs74563389	chr11:65104278-65104279	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs563684759	chr11:65104284-65104285	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs532620518	chr11:65104335-65104336	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs35038130	chr11:65104336-65104337	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs545982523	chr11:65104337-65104338	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs4930290	chr11:65104377-65104378	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
43	rs528272911	chr11:65104387-65104388	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs184541437	chr11:65104388-65104389	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs568001192	chr11:65104426-65104427	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs34231475	chr11:65104440-65104441	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs574310931	chr11:65104441-65104442	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs531869353	chr11:65104464-65104465	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs550133417	chr11:65104474-65104475	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs570117566	chr11:65104518-65104519	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:99)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Glioblastoma multiforme	21138945	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Pituitary adenoma	18645599	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	21080181	CNVD
Smith-Lemli-Opitz syndrome	21572526	CNVD
Multiple myeloma	16461302	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Metanephric adenoma	20802469	CNVD
Chordoma	21602918	CNVD
Melanoma	18172304	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
ovarian endometriomas	16273235	CNVD
Breast cancer	16417655	CNVD
Myelofibrosis	22110671	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	17217626	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	21045282	CNVD
Breast cancer	21806811	CNVD
Breast cancer	22002566	CNVD
Ductal carcinoma	18381933	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20953835	CNVD
oto-dental syndrome	17656375	CNVD
Asthma	21956041	CNVD
Breast cancer	17603634	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	20864512	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21509527	CNVD
Anaplastic thyroid cancer	18753363	CNVD
Prostate cancer	18779856	CNVD
Cancer	17160897	CNVD
Breast cancer	17001317	CNVD
Oral squamous cell carcinoma	16619035	CNVD
Intracranial aneurysm	16715129	CNVD
Colorectal cancer	16272173	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Colorectal cancer	16882699	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668395	CNVD
Spinal muscular atrophy	17668395	CNVD
Neonatal seizures	17668395	CNVD
Neonatal seizures	17668391	CNVD
Neuroticism	17667963	CNVD
Cancer	17916600	CNVD
Squamous cell cancer	19047905	CNVD
Multiple endocrine neoplasia type 1	19566914	CNVD
XY sex reversal	17503084	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668391	CNVD
Maculopathy	17646752	CNVD
Breast cancer	17899364	CNVD
Breast cancer	17157792	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:243 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:65102200-65104000	Enhancers	Spleen	Spleen
2	chr11:65102200-65105800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr11:65102400-65105800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
4	chr11:65102400-65105800	Weak transcription	Lung	lung
5	chr11:65102400-65107600	Weak transcription	Pancreas	Pancrea
6	chr11:65102400-65107800	Weak transcription	Esophagus	oesophagus
7	chr11:65102600-65103400	Enhancers	Primary T helper naive cells from peripheral blood	blood
8	chr11:65102600-65103600	Weak transcription	Fetal Muscle Trunk	muscle
9	chr11:65102600-65103600	Enhancers	Left Ventricle	heart
10	chr11:65102600-65104000	Enhancers	Primary B cells from peripheral blood	blood
11	chr11:65102600-65107400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
12	chr11:65102600-65107800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
13	chr11:65102600-65107800	Weak transcription	Aorta	Aorta
14	chr11:65102600-65108400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
15	chr11:65102800-65103400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr11:65102800-65103400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
17	chr11:65102800-65103400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
18	chr11:65102800-65103400	Active TSS	Brain Germinal Matrix	brain
19	chr11:65102800-65103400	Genic enhancers	Duodenum Smooth Muscle	Duodenum
20	chr11:65102800-65103400	Genic enhancers	Fetal Muscle Leg	muscle
21	chr11:65102800-65103400	Active TSS	Sigmoid Colon	Sigmoid Colon
22	chr11:65102800-65105400	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
23	chr11:65102800-65105600	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
24	chr11:65102800-65105800	Weak transcription	Rectal Mucosa Donor 31	rectum
25	chr11:65102800-65107200	Weak transcription	Brain Substantia Nigra	brain
26	chr11:65103000-65103400	Enhancers	Primary T killer memory cells from peripheral blood	blood
27	chr11:65103000-65103400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
28	chr11:65103000-65103400	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
29	chr11:65103000-65103400	Enhancers	Brain Hippocampus Middle	brain
30	chr11:65103000-65103400	Enhancers	Fetal Brain Male	brain
31	chr11:65103000-65103400	Enhancers	Fetal Brain Female	brain
32	chr11:65103000-65103400	Enhancers	Fetal Thymus	thymus
33	chr11:65103000-65103400	Enhancers	Thymus	Thymus
34	chr11:65103000-65103800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
35	chr11:65103000-65105600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
36	chr11:65103000-65105600	Weak transcription	Gastric	stomach
37	chr11:65103000-65105800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
38	chr11:65103000-65105800	Weak transcription	HUES48 Cell Line	embryonic stem cell
39	chr11:65103000-65105800	Weak transcription	HUES6 Cell Line	embryonic stem cell
40	chr11:65103000-65105800	Weak transcription	HUES64 Cell Line	embryonic stem cell
41	chr11:65103000-65105800	Weak transcription	Fetal Heart	heart
42	chr11:65103000-65105800	Weak transcription	Placenta	Placenta
43	chr11:65103000-65105800	Weak transcription	Right Atrium	heart
44	chr11:65103000-65105800	Weak transcription	Right Ventricle	heart
45	chr11:65103000-65105800	Weak transcription	A549	lung
46	chr11:65103000-65106000	Weak transcription	H9 Cell Line	embryonic stem cell
47	chr11:65103000-65106000	Enhancers	Primary T cells fromperipheralblood	blood
48	chr11:65103000-65106400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
49	chr11:65103000-65107600	Weak transcription	H1 Cell Line	embryonic stem cell
50	chr11:65103000-65107800	Weak transcription	iPS-15b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links